UBS Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-455,206
Closed -$31.7M 10674
2024
Q3
$31.7M Buy
455,206
+161,621
+55% +$11.1M 0.01% 1479
2024
Q2
$19.7M Sell
293,585
-45,106
-13% -$3.04M ﹤0.01% 1682
2024
Q1
$23.4M Buy
338,691
+281,143
+489% +$19M 0.01% 1568
2023
Q4
$3.58M Buy
57,548
+30,603
+114% +$1.71M ﹤0.01% 3135
2023
Q3
$1.51M Sell
26,945
-16,039
-37% -$902K ﹤0.01% 3716
2023
Q2
$2.17M Buy
42,984
+14,922
+53% +$794K ﹤0.01% 3448
2023
Q1
$1.53M Buy
28,062
+8,191
+41% +$479K ﹤0.01% 3699
2022
Q4
$1.24M Buy
19,871
+6,807
+52% +$452K ﹤0.01% 3863
2022
Q3
$920K Buy
13,064
+5,302
+68% +$366K ﹤0.01% 3817
2022
Q2
$440K Sell
7,762
-1,361
-15% -$74.6K ﹤0.01% 4353
2022
Q1
$571K Sell
9,123
-1,280
-12% -$69K ﹤0.01% 4587
2021
Q4
$583K Buy
10,403
+315
+3% +$19.2K ﹤0.01% 4845
2021
Q3
$657K Buy
10,088
+627
+7% +$42.8K ﹤0.01% 4526
2021
Q2
$600K Buy
9,461
+6,112
+183% +$361K ﹤0.01% 4586
2021
Q1
$201K Buy
3,349
+1,666
+99% +$90.6K ﹤0.01% 5482
2020
Q4
$84K Buy
1,683
+577
+52% +$27.1K ﹤0.01% 5803
2020
Q3
$56K Sell
1,106
-6,742
-86% -$281K ﹤0.01% 5569
2020
Q2
$276K Buy
7,848
+478
+6% +$16.5K ﹤0.01% 4577
2020
Q1
$187K Sell
7,370
-9,932
-57% -$295K ﹤0.01% 4772
2019
Q4
$479K Buy
17,302
+5,503
+47% +$131K ﹤0.01% 4876
2019
Q3
$318K Buy
11,799
+9,234
+360% +$322K ﹤0.01% 4902
2019
Q2
$105K Buy
2,565
+2,092
+442% +$58.8K ﹤0.01% 5347
2019
Q1
$11K Sell
473
-3,400
-88% -$61.7K ﹤0.01% 6763
2018
Q4
$59K Buy
+3,873
New +$57.7K ﹤0.01% 5959

Other funds holding AXNX